VYERA
Live / Registered — Registered (as of 15 Sept 2020)
What this means for you
Registered since 15 Sept 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use was due 15 Sept 2026; it can still be filed, with a surcharge, until 15 Mar 2027).
Record
- Serial number
- 87304375
- Registration number
- 6153504
- Mark type
- Word mark
- Filed
- 17 Jan 2017
- Published for opposition
- 20 Jun 2017
- Registered
- 15 Sept 2020
- Next maintenance filing
- §8 declaration of use, due by 15 Sept 2026 (grace period to 15 Mar 2027)
- Attorney of record
- Joshua S. Jarvis, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system; pharmaceutical preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of toxoplasmosis
Owner
- PHOENIXUS AG, Baar, CH
- PHOENIXUS AG, Baar, CH
- VYERA PHARMACEUTICALS AG, New York, NY, CH
- Turing Pharmaceuticals AG, New York, NY, CH
- Turing Pharmaceuticals AG, New York, NY, CH
Prosecution history
- 15 Sept 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 15 Sept 2020 — REGISTERED-PRINCIPAL REGISTER
- 14 Aug 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Aug 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Jul 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Jun 2020 — USE AMENDMENT FILED
- 14 Jul 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Jun 2020 — TEAS STATEMENT OF USE RECEIVED
- 22 Jan 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jan 2020 — SOU EXTENSION 5 GRANTED
- 16 Jan 2020 — SOU EXTENSION 5 FILED
- 21 Jan 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Jan 2020 — SOU TEAS EXTENSION RECEIVED
- 27 Jul 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jul 2019 — SOU EXTENSION 4 GRANTED